Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / Fund iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Issuer Blackrock
Entity holding fund iShares IV Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF Ticker BTEC(USD) LSE
ETF Ticker BTEK(GBP) LSE
ETF Ticker 2B70(EUR) F
ETF Ticker 2B70.DE(EUR) CXE
ETF Ticker BTEC.LS(USD) CXE
ETF Ticker BTEK.LS(GBP) CXE
ETF Ticker BTEC.L(GBP) LSE
ETF Ticker BTEK.L(GBP) LSE

Holdings detail for VRTX

Stock Name	Vertex Pharmaceuticals Inc
Ticker	VRTX(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US92532F1003
LEI	54930015RAQRRZ5ZGJ91

Show aggregate VRTX holdings

News associated with VRTX

Vertex Pharmaceuticals Secures Italian Reimbursement Agreement For Gene-Edited Therapy CASGEVY: (RTTNews) - Vertex Pharmaceuticals (VRTX), Thursday announced a reimbursement agreement with the Italian Medicines Agency that allows eligible transfusion-dependent beta thalassemia and severe sickle cell disease patients to access the CRISPR/Cas9 gene-edited therapy CASGEVY. - 2025-09-18 14:26:15
Why This Biotech Company Could Be a Growth Stock Powerhouse: Key PointsThis biotech is a leader in the treatment of cystic fibrosis, and that’s helped earnings explode higher over the years. - 2025-09-17 06:10:00
3 Absurdly Cheap Stocks to Buy for the Long Haul: Key PointsThese stocks are all down for the year, and things could get worse before they get better. - 2025-09-12 08:30:00
My 2 Favorite Stocks to Buy Right Now: Key PointsAmazon has multiple moats and paths to grow. - 2025-08-31 05:51:00
Capital Group Growth ETF Experiences Big Inflow: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Capital Group Growth ETF (Symbol: CGGR) where we have detected an approximate $162.3 million dollar inflow -- that's a 1.1% increase week over week i - 2025-08-29 11:52:16
Noteworthy ETF Inflows: CGBL, CGCP, CGCB, VRTX: Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Capital Group Core Balanced ETF (Symbol: CGBL) where we have detected an approximate $272.2 million dollar inflow -- that's a 9.7% increase week over - 2025-08-15 11:50:39
2 Growth Stocks That Are No-Brainer Buys Right Now: Key PointsVertex Pharmaceuticals' recent dip presents an excellent buying opportunity, given its promising prospects. - 2025-08-15 09:30:00
Vertex Pharmaceuticals (NASDAQ:VRTX) Rating Increased to Strong-Buy at Wall Street Zen: Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) was upgraded by investment analysts at Wall Street Zen from a “hold” rating to a “strong-buy” rating in a report issued on Saturday. A number of other research firms have also recently weighed in on VRTX. Wells Fargo & Company raised shares of Vertex Pharmaceuticals from an “equal […] - 2025-08-11 02:58:48
The Smartest Growth Stocks to Buy With $1,000 Right Now: Key PointsVertex Pharmaceuticals' recent sell-off was overdone. - 2025-08-09 05:46:00
5 Top Stocks to Buy in August: Key PointsThe pullback in Netflix, Costco, and ASML is a buying opportunity. - 2025-08-08 07:45:00
Harbour Investments Inc. Acquires 68 Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX): Harbour Investments Inc. increased its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 19.9% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 410 shares of the pharmaceutical company’s stock after purchasing an additional 68 shares during the period. Harbour […] - 2025-08-07 05:54:57
Vertex Pharmaceuticals (NASDAQ:VRTX) Reaches New 52-Week Low on Analyst Downgrade: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report)’s share price hit a new 52-week low during trading on Wednesday after Canaccord Genuity Group lowered their price target on the stock from $424.00 to $411.00. Canaccord Genuity Group currently has a hold rating on the stock. Vertex Pharmaceuticals traded as low as $373.19 and last traded […] - 2025-08-07 05:08:45
Scotiabank Issues Pessimistic Forecast for Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Price: Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) had its price target lowered by Scotiabank from $442.00 to $438.00 in a report released on Tuesday,Benzinga reports. The firm presently has a “sector perform” rating on the pharmaceutical company’s stock. Scotiabank’s target price suggests a potential upside of 13.57% from the company’s current price. Other research analysts […] - 2025-08-07 03:14:58
Vertex Pharmaceuticals (NASDAQ:VRTX) PT Set at $490.00 by Truist Financial: Vertex Pharmaceuticals (NASDAQ:VRTX – Get Free Report) received a $490.00 price objective from Truist Financial in a report issued on Tuesday, MarketBeat reports. The firm presently has a “buy” rating on the pharmaceutical company’s stock. Truist Financial’s price objective indicates a potential upside of 27.06% from the company’s previous close. A number of other equities […] - 2025-08-07 03:14:58
Vertex Pharmaceuticals (NASDAQ:VRTX) Shares Gap Down Following Analyst Downgrade: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report) shares gapped down before the market opened on Tuesday after Canaccord Genuity Group lowered their price target on the stock from $424.00 to $411.00. The stock had previously closed at $472.27, but opened at $408.22. Canaccord Genuity Group currently has a hold rating on the stock. Vertex […] - 2025-08-07 02:42:43
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 14:19:48
Wednesday's ETF with Unusual Volume: LSGR: The Natixis Loomis Sayles Focused Growth ETF is seeing unusually high volume in afternoon trading Wednesday, with over 805,000 shares traded versus three month average volume of about 45,000. Shares of LSGR were up about 0.4% on the day. Components of that ETF with the highest - 2025-08-06 13:11:25
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 12:43:55
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 12:20:27
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 10:31:46
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 10:01:41
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 08:50:42
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 08:02:58
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 05:54:32
Royal Bank Of Canada Lowers Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target to $405.00: Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its price objective trimmed by Royal Bank Of Canada from $430.00 to $405.00 in a research report sent to investors on Tuesday morning,Benzinga reports. The brokerage currently has a sector perform rating on the pharmaceutical company’s stock. A number of other equities research analysts have also issued reports […] - 2025-08-06 04:40:55
Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Cut to $455.00 by Analysts at Stifel Nicolaus: Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its price objective reduced by Stifel Nicolaus from $494.00 to $455.00 in a research note issued to investors on Tuesday morning,Benzinga reports. Stifel Nicolaus currently has a hold rating on the pharmaceutical company’s stock. VRTX has been the topic of several other reports. Scotiabank dropped their target price […] - 2025-08-06 04:40:55
HC Wainwright Has Lowered Expectations for Vertex Pharmaceuticals (NASDAQ:VRTX) Stock Price: Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) had its target price decreased by HC Wainwright from $550.00 to $478.00 in a research report released on Tuesday,Benzinga reports. HC Wainwright currently has a buy rating on the pharmaceutical company’s stock. A number of other equities research analysts have also recently weighed in on VRTX. Leerink Partnrs cut […] - 2025-08-06 04:40:51
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 04:21:54
Stocks Settle Lower as US Service Sector Activity Weakens: The S&P 500 Index ($SPX ) (SPY ) Tuesday closed down -0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.14%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.73%. September E-mini S&P futures (ESU25 ) fell -0.46%, and September E-mini Nasdaq futures (NQU25... - 2025-08-06 02:12:19
Stocks Pressured by Disappointing US Service Sector News: The S&P 500 Index ($SPX ) (SPY ) today is down -0.57%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.51%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.62%. September E-mini S&P futures (ESU25 ) are down -0.55%, and September E-mini Nasdaq futures... - 2025-08-05 19:47:15

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) VRTX holdings

Date	Number of VRTX Shares Held	Base Market Value of VRTX Shares	Local Market Value of VRTX Shares	Change in VRTX Shares Held	Change in VRTX Base Value	Current Price per VRTX Share Held	Previous Price per VRTX Share Held
2025-11-11 (Tuesday)	137,160	USD 58,871,815	USD 58,871,815	0	USD 1,100,023	USD 429.22	USD 421.2
2025-11-10 (Monday)	137,160	USD 57,771,792	USD 57,771,792	350	USD 1,752,201	USD 421.2	USD 409.47
2025-11-07 (Friday)	136,810	USD 56,019,591	USD 56,019,591	0	USD -927,572	USD 409.47	USD 416.25
2025-11-06 (Thursday)	136,810	USD 56,947,163	USD 56,947,163	350	USD 43,343	USD 416.25	USD 417
2025-11-05 (Wednesday)	136,460	USD 56,903,820	USD 56,903,820	0	USD -637,268	USD 417	USD 421.67
2025-11-04 (Tuesday)	136,460	USD 57,541,088	USD 57,541,088	352	USD -440,920	USD 421.67	USD 426
2025-11-03 (Monday)	136,108	USD 57,982,008	USD 57,982,008	0	USD 58,526	USD 426	USD 425.57
2025-10-31 (Friday)	136,108	USD 57,923,482	USD 57,923,482	0	USD 773,094	USD 425.57	USD 419.89
2025-10-30 (Thursday)	136,108	USD 57,150,388	USD 57,150,388	1,760	USD 1,099,059	USD 419.89	USD 417.21
2025-10-29 (Wednesday)	134,348	USD 56,051,329	USD 56,051,329	1,012	USD -268,464	USD 417.21	USD 422.39
2025-10-28 (Tuesday)	133,336	USD 56,319,793	USD 56,319,793	0	USD 296,006	USD 422.39	USD 420.17
2025-10-27 (Monday)	133,336	USD 56,023,787	USD 56,023,787	0	USD -162,670	USD 420.17	USD 421.39

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of VRTX by Blackrock for IE00BYXG2H39

Show aggregate share trades of VRTX

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-11-10 BUY 350 421.200* 455.70
2025-11-06 BUY 350 416.250* 456.13
2025-11-04 BUY 352 421.670* 456.49
2025-10-30 BUY 1,760 422.950 415.000 415.795 USD 731,799 456.99
2025-10-29 BUY 1,012 417.210 422.980 422.403 USD 427,472 457.19
2025-10-22 SELL -1,404 426.440 431.810 431.273 USD -605,507 458.10 Profit of 37,664 on sale
2025-10-20 BUY 702 419.100 420.500 420.360 USD 295,093 458.47
2025-10-17 BUY 1,754 416.810 419.370 419.114 USD 735,126 458.70
2025-10-15 BUY 2,800 407.900 413.570 413.003 USD 1,156,408 458.97
2025-10-03 BUY 2,436 403.300 411.910 411.049 USD 1,001,315 459.52
2025-10-02 BUY 348 408.850 411.000 410.785 USD 142,953 459.80
2025-09-30 BUY 696 391.640 397.650 397.049 USD 276,346 460.48
2025-09-26 BUY 696 385.740 387.480 387.306 USD 269,565 461.25
2025-09-25 BUY 696 381.870 387.480 386.919 USD 269,296 461.70
2025-09-24 BUY 26,220 376.620 380.730 380.319 USD 9,971,964 462.17
2025-09-18 BUY 270 387.110 390.660 390.305 USD 105,382 462.60
2025-09-17 BUY 813 387.150 396.310 395.394 USD 321,455 463.03
2025-09-11 SELL -271 397.370 398.500 398.387 USD -107,963 463.82 Profit of 17,731 on sale
2025-09-10 BUY 542 388.550 396.860 396.029 USD 214,648 464.25
2025-09-05 SELL -271 396.120 402.740 402.078 USD -108,963 465.46 Profit of 17,176 on sale
2025-08-20 SELL -1,084 394.360 400.940 400.282 USD -433,906 466.74 Profit of 72,036 on sale
2025-08-18 BUY 542 389.880 395.610 395.037 USD 214,110 467.66
2025-07-30 BUY 1,245 469.160 474.760 474.200 USD 590,379 469.15
2025-07-17 SELL -540 463.270 472.220 471.325 USD -254,516 469.30 Loss of -1,093 on sale
2025-07-16 BUY 902 469.550 470.940 470.801 USD 424,663 469.30
2025-07-11 SELL -2,144 468.850 478.270 477.328 USD -1,023,391 469.32 Loss of -17,178 on sale
2025-07-07 BUY 804 459.410 461.250 461.066 USD 370,697 469.27
2025-07-02 BUY 14,740 457.030 457.750 457.678 USD 6,746,174 469.42
2025-06-20 SELL -2,964 440.870 451.810 450.716 USD -1,335,922 469.63 Profit of 56,050 on sale
2025-06-13 BUY 154 455.450 460.100 459.635 USD 70,784 470.39
2025-06-11 BUY 554 452.440 460.330 459.541 USD 254,586 470.60
2025-06-10 BUY 554 451.520 455.640 455.228 USD 252,196 470.75
2025-06-04 SELL -277 445.850 453.870 453.068 USD -125,500 471.50 Profit of 5,106 on sale
2025-04-23 BUY 277 492.420 498.410 497.811 USD 137,894 476.10
2025-04-10 SELL -2,216 475.490 480.000 479.549 USD -1,062,681 474.94 Loss of -10,222 on sale
2025-04-08 SELL -277 472.370 483.940 482.783 USD -133,731 474.88 Loss of -2,189 on sale
2025-04-07 SELL -277 474.560 481.740 481.022 USD -133,243 474.88 Loss of -1,700 on sale
2025-04-04 SELL -1,385 474.620 499.070 496.625 USD -687,826 474.89 Loss of -30,106 on sale
2025-04-01 BUY 2,380 484.740 491.930 491.211 USD 1,169,082 474.67
2025-03-31 SELL -819 484.820 487.130 486.899 USD -398,770 474.54 Loss of -10,121 on sale
2025-03-21 SELL -4,857 503.200 510.080 509.392 USD -2,474,117 472.28 Loss of -180,276 on sale
2025-03-14 SELL -4,624 504.770 519.680 518.189 USD -2,396,106 469.57 Loss of -224,815 on sale
2025-03-07 SELL -578 488.290 492.340 491.935 USD -284,338 467.64 Loss of -14,040 on sale
2025-03-04 SELL -289 486.220 490.700 490.252 USD -141,683 466.68 Loss of -6,812 on sale
2025-02-25 BUY 578 480.350 486.140 485.561 USD 280,654 465.58
2025-02-19 SELL -289 471.760 472.120 472.084 USD -136,432 464.55 Loss of -2,176 on sale
2025-02-13 BUY 867 462.580 465.680 465.370 USD 403,476 464.86
2025-02-12 BUY 289 453.200 455.660 455.414 USD 131,615 465.10
2025-02-11 BUY 1,156 455.220 468.190 466.893 USD 539,728 465.31
2025-01-02 BUY 141 405.760 409.600 409.216 USD 57,699 469.47
2024-12-30 SELL -470 399.350 407.350 406.550 USD -191,079 471.59 Profit of 30,571 on sale
2024-11-18 SELL -4,290 467.010 468.880 468.693 USD -2,010,693 482.32 Profit of 58,449 on sale
2024-11-08 SELL -286 516.740 519.880 519.566 USD -148,596 479.31 Loss of -11,513 on sale
2024-10-30 BUY 152 475.080 475.460 475.422 USD 72,264 474.20
2024-10-21 SELL -285 478.090 487.880 486.901 USD -138,767 0.00 Loss of -138,767 on sale
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-11-10	BUY	350			421.200*		455.70
2025-11-06	BUY	350			416.250*		456.13
2025-11-04	BUY	352			421.670*		456.49
2025-10-30	BUY	1,760	422.950	415.000	415.795	USD 731,799	456.99
2025-10-29	BUY	1,012	417.210	422.980	422.403	USD 427,472	457.19
2025-10-22	SELL	-1,404	426.440	431.810	431.273	USD -605,507	458.10 Profit of 37,664 on sale
2025-10-20	BUY	702	419.100	420.500	420.360	USD 295,093	458.47
2025-10-17	BUY	1,754	416.810	419.370	419.114	USD 735,126	458.70
2025-10-15	BUY	2,800	407.900	413.570	413.003	USD 1,156,408	458.97
2025-10-03	BUY	2,436	403.300	411.910	411.049	USD 1,001,315	459.52
2025-10-02	BUY	348	408.850	411.000	410.785	USD 142,953	459.80
2025-09-30	BUY	696	391.640	397.650	397.049	USD 276,346	460.48
2025-09-26	BUY	696	385.740	387.480	387.306	USD 269,565	461.25
2025-09-25	BUY	696	381.870	387.480	386.919	USD 269,296	461.70
2025-09-24	BUY	26,220	376.620	380.730	380.319	USD 9,971,964	462.17
2025-09-18	BUY	270	387.110	390.660	390.305	USD 105,382	462.60
2025-09-17	BUY	813	387.150	396.310	395.394	USD 321,455	463.03
2025-09-11	SELL	-271	397.370	398.500	398.387	USD -107,963	463.82 Profit of 17,731 on sale
2025-09-10	BUY	542	388.550	396.860	396.029	USD 214,648	464.25
2025-09-05	SELL	-271	396.120	402.740	402.078	USD -108,963	465.46 Profit of 17,176 on sale
2025-08-20	SELL	-1,084	394.360	400.940	400.282	USD -433,906	466.74 Profit of 72,036 on sale
2025-08-18	BUY	542	389.880	395.610	395.037	USD 214,110	467.66
2025-07-30	BUY	1,245	469.160	474.760	474.200	USD 590,379	469.15
2025-07-17	SELL	-540	463.270	472.220	471.325	USD -254,516	469.30 Loss of -1,093 on sale
2025-07-16	BUY	902	469.550	470.940	470.801	USD 424,663	469.30
2025-07-11	SELL	-2,144	468.850	478.270	477.328	USD -1,023,391	469.32 Loss of -17,178 on sale
2025-07-07	BUY	804	459.410	461.250	461.066	USD 370,697	469.27
2025-07-02	BUY	14,740	457.030	457.750	457.678	USD 6,746,174	469.42
2025-06-20	SELL	-2,964	440.870	451.810	450.716	USD -1,335,922	469.63 Profit of 56,050 on sale
2025-06-13	BUY	154	455.450	460.100	459.635	USD 70,784	470.39
2025-06-11	BUY	554	452.440	460.330	459.541	USD 254,586	470.60
2025-06-10	BUY	554	451.520	455.640	455.228	USD 252,196	470.75
2025-06-04	SELL	-277	445.850	453.870	453.068	USD -125,500	471.50 Profit of 5,106 on sale
2025-04-23	BUY	277	492.420	498.410	497.811	USD 137,894	476.10
2025-04-10	SELL	-2,216	475.490	480.000	479.549	USD -1,062,681	474.94 Loss of -10,222 on sale
2025-04-08	SELL	-277	472.370	483.940	482.783	USD -133,731	474.88 Loss of -2,189 on sale
2025-04-07	SELL	-277	474.560	481.740	481.022	USD -133,243	474.88 Loss of -1,700 on sale
2025-04-04	SELL	-1,385	474.620	499.070	496.625	USD -687,826	474.89 Loss of -30,106 on sale
2025-04-01	BUY	2,380	484.740	491.930	491.211	USD 1,169,082	474.67
2025-03-31	SELL	-819	484.820	487.130	486.899	USD -398,770	474.54 Loss of -10,121 on sale
2025-03-21	SELL	-4,857	503.200	510.080	509.392	USD -2,474,117	472.28 Loss of -180,276 on sale
2025-03-14	SELL	-4,624	504.770	519.680	518.189	USD -2,396,106	469.57 Loss of -224,815 on sale
2025-03-07	SELL	-578	488.290	492.340	491.935	USD -284,338	467.64 Loss of -14,040 on sale
2025-03-04	SELL	-289	486.220	490.700	490.252	USD -141,683	466.68 Loss of -6,812 on sale
2025-02-25	BUY	578	480.350	486.140	485.561	USD 280,654	465.58
2025-02-19	SELL	-289	471.760	472.120	472.084	USD -136,432	464.55 Loss of -2,176 on sale
2025-02-13	BUY	867	462.580	465.680	465.370	USD 403,476	464.86
2025-02-12	BUY	289	453.200	455.660	455.414	USD 131,615	465.10
2025-02-11	BUY	1,156	455.220	468.190	466.893	USD 539,728	465.31
2025-01-02	BUY	141	405.760	409.600	409.216	USD 57,699	469.47
2024-12-30	SELL	-470	399.350	407.350	406.550	USD -191,079	471.59 Profit of 30,571 on sale
2024-11-18	SELL	-4,290	467.010	468.880	468.693	USD -2,010,693	482.32 Profit of 58,449 on sale
2024-11-08	SELL	-286	516.740	519.880	519.566	USD -148,596	479.31 Loss of -11,513 on sale
2024-10-30	BUY	152	475.080	475.460	475.422	USD 72,264	474.20
2024-10-21	SELL	-285	478.090	487.880	486.901	USD -138,767	0.00 Loss of -138,767 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of VRTX

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	253,408	88	822,586	30.8%
2025-09-18	262,277	45	831,580	31.5%
2025-09-17	158,866	890	1,012,591	15.7%
2025-09-16	233,484	702	769,823	30.3%
2025-09-15	385,606	97	605,410	63.7%
2025-09-12	198,306	54	325,925	60.8%
2025-09-11	217,651	160	455,823	47.7%
2025-09-10	441,550	65	640,409	68.9%
2025-09-09	216,563	711	395,377	54.8%
2025-09-08	285,371	226	594,102	48.0%
2025-09-05	209,916	9	413,663	50.7%
2025-09-04	236,777	2,164	365,713	64.7%
2025-09-03	212,085	7	457,751	46.3%
2025-09-02	318,587	425	689,371	46.2%
2025-08-29	136,055	7	344,317	39.5%
2025-08-28	189,040	229	437,536	43.2%
2025-08-27	204,685	373	919,772	22.3%
2025-08-26	195,209	380	616,641	31.7%
2025-08-25	205,216	929	405,536	50.6%
2025-08-22	187,538	366	477,729	39.3%
2025-08-21	357,256	454	694,264	51.5%
2025-08-20	304,195	196	620,591	49.0%
2025-08-19	193,253	370	598,168	32.3%
2025-08-18	197,043	357	581,908	33.9%
2025-08-15	213,454	413	509,240	41.9%
2025-08-14	299,335	536	798,768	37.5%
2025-08-13	342,897	6,746	694,047	49.4%
2025-08-12	361,071	536	689,425	52.4%
2025-08-11	478,787	177	1,141,772	41.9%
2025-08-08	382,688	480	1,467,480	26.1%
2025-08-07	802,775	500	1,747,924	45.9%
2025-08-06	1,070,384	29,978	2,256,489	47.4%
2025-08-05	2,087,742	66,027	4,981,303	41.9%
2025-08-04	329,631	253	766,131	43.0%
2025-08-01	290,545	239	729,079	39.9%
2025-07-31	227,826	151	513,336	44.4%
2025-07-30	134,793	234	361,144	37.3%
2025-07-29	124,474	331	372,446	33.4%
2025-07-28	125,989	264	519,868	24.2%
2025-07-25	136,582	104	432,897	31.6%
2025-07-24	144,869	169	321,736	45.0%
2025-07-23	182,307	1,460	370,788	49.2%
2025-07-22	193,759	402	450,155	43.0%
2025-07-21	174,382	14,621	318,671	54.7%
2025-07-18	203,357	10,091	296,802	68.5%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
Issuer	Blackrock
Entity holding fund	iShares IV Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300ZP07LMR36K1T02
ETF Ticker	BTEC(USD) LSE
ETF Ticker	BTEK(GBP) LSE
ETF Ticker	2B70(EUR) F
ETF Ticker	2B70.DE(EUR) CXE
ETF Ticker	BTEC.LS(USD) CXE
ETF Ticker	BTEK.LS(GBP) CXE
ETF Ticker	BTEC.L(GBP) LSE
ETF Ticker	BTEK.L(GBP) LSE